NASDAQ:GLTO Galecto (GLTO) Stock Price, News & Analysis $3.25 -0.04 (-1.09%) As of 08/1/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Galecto Stock (NASDAQ:GLTO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Galecto alerts:Sign Up Key Stats Today's Range$3.14▼$3.2650-Day Range$2.98▼$3.9052-Week Range$2.01▼$15.13Volume4,417 shsAverage Volume29,599 shsMarket Capitalization$4.26 millionP/E RatioN/ADividend YieldN/APrice Target$10.00Consensus RatingBuy Company Overview Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark. Read More Galecto Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreGLTO MarketRank™: Galecto scored higher than 47% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingGalecto has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageGalecto has received no research coverage in the past 90 days.Read more about Galecto's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Galecto are expected to grow in the coming year, from ($15.91) to ($13.54) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Galecto is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Galecto is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioGalecto has a P/B Ratio of 0.29. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Galecto's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.47% of the float of Galecto has been sold short.Short Interest Ratio / Days to CoverGalecto has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Galecto has recently increased by 7.32%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGalecto does not currently pay a dividend.Dividend GrowthGalecto does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.47% of the float of Galecto has been sold short.Short Interest Ratio / Days to CoverGalecto has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Galecto has recently increased by 7.32%, indicating that investor sentiment is decreasing significantly. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Galecto this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Galecto insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,983.00 in company stock.Percentage Held by Insiders10.80% of the stock of Galecto is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 14.20% of the stock of Galecto is held by institutions.Read more about Galecto's insider trading history. Receive GLTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Galecto and its competitors with MarketBeat's FREE daily newsletter. Email Address GLTO Stock News HeadlinesGalecto (NASDAQ:GLTO) Stock Price Down 7.5% - Here's What HappenedJuly 31 at 3:41 AM | americanbankingnews.comGalecto, Inc. (GLTO) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | sg.finance.yahoo.comBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%. | Altimetry (Ad)Galecto, Inc. Reports First Quarter 2025 Financial Results and Progress on AML Treatment DevelopmentMay 10, 2025 | nasdaq.comGalecto, Inc.: Galecto Reports First Quarter 2025 Operating and Financial ResultsMay 9, 2025 | finanznachrichten.deGalecto Reports First Quarter 2025 Operating and Financial ResultsMay 8, 2025 | globenewswire.comGalecto (GLTO)April 12, 2025 | es.investing.comGalecto, Inc. Focuses on Oncology and Liver DiseasesApril 3, 2025 | tipranks.comSee More Headlines GLTO Stock Analysis - Frequently Asked Questions How have GLTO shares performed this year? Galecto's stock was trading at $4.65 on January 1st, 2025. Since then, GLTO shares have decreased by 30.6% and is now trading at $3.2250. How were Galecto's earnings last quarter? Galecto, Inc. (NASDAQ:GLTO) issued its quarterly earnings data on Thursday, May, 8th. The company reported ($1.92) earnings per share (EPS) for the quarter. When did Galecto's stock split? Galecto shares reverse split on Friday, August 30th 2024.The 1-25 reverse split was announced on Wednesday, August 28th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. When did Galecto IPO? Galecto (GLTO) raised $86 million in an initial public offering on Thursday, October 29th 2020. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. BofA Securities, SVB Leerink and Credit Suisse served as the underwriters for the IPO and Kempen & Co. was co-manager. How do I buy shares of Galecto? Shares of GLTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Galecto own? Based on aggregate information from My MarketBeat watchlists, some other companies that Galecto investors own include Medical Properties Trust (MPW), Realty Income (O), Oxford Square Capital (OXSQ), Plug Power (PLUG), AGNC Investment (AGNC), Aberdeen Total Dynamic Dividend Fund (AOD) and Abrdn Global Infrastructure Income Fund (ASGI). Company Calendar Last Earnings5/08/2025Today8/02/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:GLTO CIK1800315 Webgalecto.com Phone45-7070-5210FaxN/AEmployees40Year FoundedN/APrice Target and Rating Average Price Target for Galecto$10.00 High Price Target$10.00 Low Price Target$10.00 Potential Upside/Downside+210.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($15.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$21.44 million Net MarginsN/A Pretax MarginN/A Return on Equity-98.27% Return on Assets-84.29% Debt Debt-to-Equity RatioN/A Current Ratio9.62 Quick Ratio9.62 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$10.99 per share Price / Book0.29Miscellaneous Outstanding Shares1,320,000Free Float1,179,000Market Cap$4.26 million OptionableOptionable Beta1.35 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:GLTO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galecto, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galecto With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.